TARGETING THE ANTIAPOPTOTIC PROTEIN SURVIVING FOR PROTEASOMAL DEGRADATION: APPLICATIONS IN ER/PR-NEGATIVE, INVASIVE, DRUG-RESISTANT, AND TYPICAL BREA

University Of Utah, Salt Lake City UT

Investigators